Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Link
http://www.nature.com/articles/s41568-020-0246-1.pdf
Reference169 articles.
1. Delaney, G., Jacob, S., Featherstone, C. & Barton, M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104, 1129–1137 (2005).
2. Formenti, S. C. et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat. Med. 24, 1845–1851 (2018). This study reports the induction of systemic antitumour T cells in metastatic NSCLC by radiation therapy and CTLA4 blockade. This was observed in chemo-refractory patients where anti-CTLA4 alone failed to demonstrate significant efficacy.
3. Antonia, S. J. et al. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N. Engl. J. Med. 379, 2342–2350 (2018).
4. Dillon, M. T. et al. Radiosensitization by the ATR inhibitor AZD6738 through generation of acentric micronuclei. Mol. Cancer Ther. 16, 25–34 (2017).
5. Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466–470 (2017).
Cited by 508 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bifunctional black phosphorus quantum dots platform: Delivery and remarkable immunotherapy enhancement of STING agonist;Biomaterials;2024-12
2. Nanomolecular machines: Pioneering precision medicine for neoplastic diseases through advanced diagnosis and treatment;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12
3. Firing up “cold” tumors: Ferroptosis causes immune activation by improving T cell infiltration;Biomedicine & Pharmacotherapy;2024-10
4. Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors;Radiotherapy and Oncology;2024-10
5. In situ enzymatic peptide-based nanomedicine with combined effects for enhanced tumor radio-immunotherapy;Chemical Engineering Journal;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3